vs
Side-by-side financial comparison of Clarus Corp (CLAR) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $65.4M, roughly 1.9× Clarus Corp). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs -47.8%, a 51.1% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs -8.4%). Clarus Corp produced more free cash flow last quarter ($11.6M vs $7.6M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs -2.9%).
Clarus Corp is a global designer, manufacturer, and distributor of high-performance outdoor recreation, climbing, camping, and lifestyle products. It manages a portfolio of leading consumer brands, serving outdoor enthusiasts, professional athletes, and retail partners across North America, Europe, and the Asia-Pacific region, with a focus on innovative, durable gear for active lifestyles.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
CLAR vs NATR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $65.4M | $123.8M |
| Net Profit | $-31.3M | $4.1M |
| Gross Margin | 27.7% | 72.5% |
| Operating Margin | -59.6% | 4.3% |
| Net Margin | -47.8% | 3.3% |
| Revenue YoY | -8.4% | 4.7% |
| Net Profit YoY | 52.3% | 1379.4% |
| EPS (diluted) | $-0.81 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $65.4M | $123.8M | ||
| Q3 25 | $69.3M | $128.3M | ||
| Q2 25 | $55.2M | $114.8M | ||
| Q1 25 | $60.4M | $113.2M | ||
| Q4 24 | $71.4M | $118.2M | ||
| Q3 24 | $67.1M | $114.6M | ||
| Q2 24 | $56.5M | $110.6M | ||
| Q1 24 | $69.3M | $111.0M |
| Q4 25 | $-31.3M | $4.1M | ||
| Q3 25 | $-1.6M | $5.3M | ||
| Q2 25 | $-8.4M | $5.3M | ||
| Q1 25 | $-5.2M | $4.7M | ||
| Q4 24 | $-65.5M | $-321.0K | ||
| Q3 24 | $-3.2M | $4.3M | ||
| Q2 24 | $-5.5M | $1.3M | ||
| Q1 24 | $21.9M | $2.3M |
| Q4 25 | 27.7% | 72.5% | ||
| Q3 25 | 35.1% | 73.3% | ||
| Q2 25 | 35.6% | 71.7% | ||
| Q1 25 | 34.4% | 72.1% | ||
| Q4 24 | 33.4% | 72.0% | ||
| Q3 24 | 35.0% | 71.3% | ||
| Q2 24 | 36.1% | 71.4% | ||
| Q1 24 | 35.9% | 71.2% |
| Q4 25 | -59.6% | 4.3% | ||
| Q3 25 | -4.4% | 7.0% | ||
| Q2 25 | -19.7% | 3.7% | ||
| Q1 25 | -11.2% | 5.4% | ||
| Q4 24 | -70.2% | 3.8% | ||
| Q3 24 | -8.0% | 4.6% | ||
| Q2 24 | -14.4% | 5.1% | ||
| Q1 24 | -9.8% | 4.2% |
| Q4 25 | -47.8% | 3.3% | ||
| Q3 25 | -2.3% | 4.2% | ||
| Q2 25 | -15.3% | 4.6% | ||
| Q1 25 | -8.7% | 4.2% | ||
| Q4 24 | -91.8% | -0.3% | ||
| Q3 24 | -4.7% | 3.8% | ||
| Q2 24 | -9.7% | 1.2% | ||
| Q1 24 | 31.6% | 2.1% |
| Q4 25 | $-0.81 | $0.23 | ||
| Q3 25 | $-0.04 | $0.30 | ||
| Q2 25 | $-0.22 | $0.28 | ||
| Q1 25 | $-0.14 | $0.25 | ||
| Q4 24 | $-1.72 | $-0.02 | ||
| Q3 24 | $-0.08 | $0.23 | ||
| Q2 24 | $-0.14 | $0.07 | ||
| Q1 24 | $0.57 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.7M | $93.9M |
| Total DebtLower is stronger | $0 | — |
| Stockholders' EquityBook value | $196.4M | $161.6M |
| Total Assets | $249.0M | $261.1M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.7M | $93.9M | ||
| Q3 25 | $29.5M | $95.6M | ||
| Q2 25 | $28.5M | $81.3M | ||
| Q1 25 | $41.3M | $86.5M | ||
| Q4 24 | $45.4M | $84.7M | ||
| Q3 24 | $36.4M | $78.7M | ||
| Q2 24 | $46.2M | $68.7M | ||
| Q1 24 | $47.5M | $77.8M |
| Q4 25 | $0 | — | ||
| Q3 25 | $2.0M | — | ||
| Q2 25 | $1.9M | — | ||
| Q1 25 | $1.9M | — | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $37.0K | $2.1M |
| Q4 25 | $196.4M | $161.6M | ||
| Q3 25 | $225.8M | $166.7M | ||
| Q2 25 | $225.1M | $163.7M | ||
| Q1 25 | $229.3M | $167.1M | ||
| Q4 24 | $233.1M | $161.0M | ||
| Q3 24 | $308.5M | $162.6M | ||
| Q2 24 | $307.3M | $156.4M | ||
| Q1 24 | $310.4M | $159.7M |
| Q4 25 | $249.0M | $261.1M | ||
| Q3 25 | $283.1M | $264.8M | ||
| Q2 25 | $286.5M | $254.9M | ||
| Q1 25 | $292.8M | $252.7M | ||
| Q4 24 | $294.1M | $240.9M | ||
| Q3 24 | $375.3M | $245.3M | ||
| Q2 24 | $369.4M | $235.8M | ||
| Q1 24 | $377.0M | $247.3M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.00× | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.5M | $9.9M |
| Free Cash FlowOCF − Capex | $11.6M | $7.6M |
| FCF MarginFCF / Revenue | 17.7% | 6.1% |
| Capex IntensityCapex / Revenue | 1.4% | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.9M | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.5M | $9.9M | ||
| Q3 25 | $-5.7M | $18.5M | ||
| Q2 25 | $-9.4M | $4.3M | ||
| Q1 25 | $-2.1M | $2.6M | ||
| Q4 24 | $16.6M | $12.2M | ||
| Q3 24 | $-8.3M | $9.6M | ||
| Q2 24 | $834.0K | $1.3M | ||
| Q1 24 | $-16.4M | $2.2M |
| Q4 25 | $11.6M | $7.6M | ||
| Q3 25 | $-7.0M | $16.8M | ||
| Q2 25 | $-11.3M | $3.0M | ||
| Q1 25 | $-3.3M | $1.5M | ||
| Q4 24 | $14.4M | $10.0M | ||
| Q3 24 | $-9.4M | $7.9M | ||
| Q2 24 | $-744.0K | $-2.0M | ||
| Q1 24 | $-18.3M | $-1.5M |
| Q4 25 | 17.7% | 6.1% | ||
| Q3 25 | -10.0% | 13.1% | ||
| Q2 25 | -20.4% | 2.6% | ||
| Q1 25 | -5.4% | 1.3% | ||
| Q4 24 | 20.1% | 8.5% | ||
| Q3 24 | -14.0% | 6.9% | ||
| Q2 24 | -1.3% | -1.9% | ||
| Q1 24 | -26.3% | -1.4% |
| Q4 25 | 1.4% | 1.9% | ||
| Q3 25 | 1.8% | 1.3% | ||
| Q2 25 | 3.4% | 1.2% | ||
| Q1 25 | 2.0% | 1.0% | ||
| Q4 24 | 3.1% | 1.9% | ||
| Q3 24 | 1.6% | 1.5% | ||
| Q2 24 | 2.8% | 3.0% | ||
| Q1 24 | 2.7% | 3.3% |
| Q4 25 | — | 2.41× | ||
| Q3 25 | — | 3.46× | ||
| Q2 25 | — | 0.81× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.21× | ||
| Q2 24 | — | 0.97× | ||
| Q1 24 | -0.75× | 0.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLAR
| Other | $37.1M | 57% |
| Outdoor Segment | $25.3M | 39% |
| Adventure Segment | $3.0M | 5% |
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
